SB 204269

Known as: SB-204269 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2001
01219972001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
1. The effects of tonabersat (SB-220453) were evaluated on trigeminal nerve ganglion stimulation-induced sensory-autonomic… (More)
Is this relevant?
2000
2000
SB-204269 (trans-(+)-6-acetyl-4S-(4-fluorobenzoylamino)-3, 4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3R-ol) shows anticonvulsant… (More)
Is this relevant?
2000
2000
The present study describes the solubilisation of the novel anticonvulsant, SB-204269, binding site from pig cortical membranes… (More)
Is this relevant?
2000
2000
SAR studies around a series of N-(tetrahydroisoquinolinyl)-2-methoxybenzamides, identified by high-throughput screening at the… (More)
Is this relevant?
1999
1999
The novel anticonvulsant SB-204269 inhibits epileptiform afterdischarges induced by high K+ in rat hippocampal slices. Its… (More)
Is this relevant?
1998
1998
SB-204269 is an anticonvulsant agent under development by SmithKline Beecham, It is in phase II clinical trials as a potential… (More)
Is this relevant?
1998
1998
On December 3, 1998, the Society for Medicines Research held a meeting entitled Trends in Medicinal Chemistry at the National… (More)
Is this relevant?
1998
1998
A series of N-(tetrahydroisoquinolinyl)-2-methoxybenzamides was identified by high-throughput screening at the novel SB-204269… (More)
Is this relevant?
1997
1997
1. SB-204269 (trans-(+)-6-acetyl-4S-(4-fluorobenzoylamino)-3, 4-dihydro-2,2-dimethyl-2H-benzol[b]pyran-3R-ol, hemihydrate) shows… (More)
Is this relevant?
1997
1997
1. Earlier optimization of structure-activity relationships in a novel series of 4-(benzoylamino)-benzopyrans, led to the… (More)
Is this relevant?